Beyond the usual workup: severe hypertriglyceridemia as a potential cause of cerebral venous thrombosis
Bleeding, Thrombosis and Vascular Biology · Published 2026-07-15 · DOI 10.4081/btvb.2026.477
Free full text
Authors (5)
Arnaud Lapostolle, Randa Khani-Bittar, Julie Mazoyer, Astrid De Liege, Bertrand Degos
Abstract
Hypertriglyceridemia and cerebral venous thrombosis are well-recognized complications of asparaginase therapy for B-cell acute lymphoblastic leukemia. Hypertriglyceridemia has also been associated with an increased risk of thrombosis in conditions such as Behçet’s disease and has been implicated in a pediatric case of cerebral venous thrombosis, suggesting a possible link between hypertriglyceridemia and cerebral venous thrombosis. We present the case of a patient with acute delirium and amnesia, revealing a venous infarction caused by cerebral venous thrombosis of the sinus rectus. Classical causes, including hereditary thrombophilia, were excluded. Notably, the patient’s blood appeared lactescent at admission, and laboratory testing revealed severe hypertriglyceridemia. The patient improved significantly with heparin, dietary modifications, and ciprofibrate. This case suggests that severe hypertriglyceridemia should be considered as a potential trigger of cerebral venous thrombosis and that including a lipid panel in cerebral venous thrombosis work-ups could be considered, allowing subsequent specific therapeutic interventions.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Lapostolle, A., Khani-Bittar, R., Mazoyer, J., et al. (2026). Beyond the usual workup: severe hypertriglyceridemia as a potential cause of cerebral venous thrombosis. Bleeding, Thrombosis and Vascular Biology. https://doi.org/10.4081/btvb.2026.477
Related articles
- In this issue · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Development of a shared decision-making tool for gene therapy in hemophilia A in Italy · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Hormones, cancer, and thrombosis: sex-specific mechanisms at the interface of hemostasis and vascular biology · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Platelet-derived thromboxane A2 induces cyclooxygenase-2 and epithelial-mesenchymal transition marker genes in U-87MG human glioblastoma cells · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- To P or not to P. That is the wrong question. · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Availability of direct oral anticoagulants testing among Italian anticoagulation clinics: a rapid evolution of clinical practice · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Pharmacokinetic interactions between anticancer drugs and direct oral anticoagulants: clinical implications for safe anticoagulation · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Thromboprophylaxis in primary brain cancer · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal
- Efficacy, safety and surgical management with concizumab prophylaxis in three young patients affected by severe hemophilia with inhibitors · Bleeding, Thrombosis and Vascular Biology · 2025 · Same journal
- Factor XI inhibitors in cancer-associated venous thromboembolism: what’s next? · Bleeding, Thrombosis and Vascular Biology · 2026 · Same journal